24
Participants
Start Date
May 9, 2022
Primary Completion Date
May 30, 2023
Study Completion Date
June 13, 2023
Vonoprazan
Oral Tablet
University of Rochester Medical Center, Rochester
PriMED Clinical Research, Dayton
Preferred Research Partners, Inc., Little Rock
ARC Clinical Research at Four Points, Austin
Pediatric Gastro, El Paso
Advanced Research Center - Elligo, Anaheim
University of South Alabama (USA) Physicians Group, Mobile
Infinite Clinical Trials, Morrow
Legacy Clinical Solutions: Tandem Clinical Research, LLC, Marrero
Boston Specialists, Boston
Lead Sponsor
Phathom Pharmaceuticals, Inc.
INDUSTRY